BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 15042800)

  • 1. Current issues in hormone replacement therapy.
    Timins JK
    N J Med; 2004 Mar; 101(3):21-7. PubMed ID: 15042800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical issues and hormone replacement therapy.
    Harris PF
    Curr Womens Health Rep; 2002 Oct; 2(5):373-81. PubMed ID: 12215310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of hormone replacement therapy--overview and update.
    Calaf i Alsina J
    Int J Fertil Womens Med; 1997; 42 Suppl 2():329-46. PubMed ID: 9397382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy in women with a history of breast cancer.
    Ylikorkala O; Metsä-Heikkilä M
    Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Historical perspective of hormone replacement therapy].
    Chanson P
    Rev Prat; 2005 Feb; 55(4):369-75. PubMed ID: 15828614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Justification for the use of HRT in the long-term prevention of osteoporosis.
    Stevenson JC
    Maturitas; 2005 Jun; 51(2):113-26. PubMed ID: 15917151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated].
    Emons G; Westphalen S
    MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy in postmenopausal women.
    Staren ED; Omer S
    Am J Surg; 2004 Aug; 188(2):136-49. PubMed ID: 15249239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women.
    Licznerska BE; Baer-Dubowska W
    Acta Pol Pharm; 2005; 62(3):241-7. PubMed ID: 16193819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 12. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormone replacement therapy: curse or blessing?].
    Schmidt M; Fink D; Lang U; Kimmig R
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):165. PubMed ID: 17068400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progestogen therapy in postmenopausal women.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S88-102. PubMed ID: 19007655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New insights on the effects of hormone replacement therapy on the breast tissue and the orgnaism].
    Kubista E
    Wien Klin Wochenschr; 2003; 115 Suppl 2():46-9. PubMed ID: 15518146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A personal initiative for women's health: to challenge the Women's Health Initiative.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adverse cardiovascular effects of postmenopausal hormone replacement therapy].
    Middeldorp S; Büller HR; Vandenbroucke JP; Helmerhorst FM; Rosendaal FR
    Ned Tijdschr Geneeskd; 2002 Nov; 146(45):2123-7. PubMed ID: 12474549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy: real concerns and false alarms.
    Bluming AZ; Tavris C
    Cancer J; 2009; 15(2):93-104. PubMed ID: 19390302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Few Alternatives As HRT 'Fountain of Youth' Runs Dry.
    Schultz J
    J Natl Cancer Inst; 2004 Aug; 96(16):1202-3. PubMed ID: 15316054
    [No Abstract]   [Full Text] [Related]  

  • 20. Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.
    Johansen OE; Qvigstad E
    Adv Ther; 2008 Jun; 25(6):525-51. PubMed ID: 18568306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.